🇺🇸 Kemadrine in United States

2,718 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Vomiting — 405 reports (14.9%)
  2. Schizophrenia — 330 reports (12.14%)
  3. Psychotic Disorder — 295 reports (10.85%)
  4. Pneumonia — 283 reports (10.41%)
  5. Drug Interaction — 274 reports (10.08%)
  6. Nausea — 252 reports (9.27%)
  7. Off Label Use — 225 reports (8.28%)
  8. Condition Aggravated — 224 reports (8.24%)
  9. Cholelithiasis — 218 reports (8.02%)
  10. Toxicity To Various Agents — 212 reports (7.8%)

Source database →

Kemadrine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Kemadrine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Kemadrine in United States?

Marketing authorisation holder not available in our data.